148 related articles for article (PubMed ID: 33405176)
1. Development of a cell-based pathway modulator screening system to screen the targeted cancer therapeutic candidates.
Panneerpandian P; Ganesan K
Hum Cell; 2021 Mar; 34(2):445-456. PubMed ID: 33405176
[TBL] [Abstract][Full Text] [Related]
2. Abacavir induces the transcriptional activity of YY1 and other oncogenic transcription factors in gastric cancer cells.
Panneerpandian P; Devanandan HJ; Marimuthu A; Karthikeyan C; Ganesan K
Antiviral Res; 2020 Feb; 174():104695. PubMed ID: 31846633
[TBL] [Abstract][Full Text] [Related]
3. A c-Myc activation sensor-based high-throughput drug screening identifies an antineoplastic effect of nitazoxanide.
Fan-Minogue H; Bodapati S; Solow-Cordero D; Fan A; Paulmurugan R; Massoud TF; Felsher DW; Gambhir SS
Mol Cancer Ther; 2013 Sep; 12(9):1896-905. PubMed ID: 23825064
[TBL] [Abstract][Full Text] [Related]
4. A useful approach to identify novel small-molecule inhibitors of Wnt-dependent transcription.
Ewan K; Pajak B; Stubbs M; Todd H; Barbeau O; Quevedo C; Botfield H; Young R; Ruddle R; Samuel L; Battersby A; Raynaud F; Allen N; Wilson S; Latinkic B; Workman P; McDonald E; Blagg J; Aherne W; Dale T
Cancer Res; 2010 Jul; 70(14):5963-73. PubMed ID: 20610623
[TBL] [Abstract][Full Text] [Related]
5. Identification of approved and investigational drugs that inhibit hypoxia-inducible factor-1 signaling.
Hsu CW; Huang R; Khuc T; Shou D; Bullock J; Grooby S; Griffin S; Zou C; Little A; Astley H; Xia M
Oncotarget; 2016 Feb; 7(7):8172-83. PubMed ID: 26882567
[TBL] [Abstract][Full Text] [Related]
6. High-Throughput Screening and Triage Assays Identify Small Molecules Targeting c-MYC in Cancer Cells.
Kallal LA; Waszkiewicz A; Jaworski JP; Della Pietra A; Berrodin T; Brady P; Jurewicz AJ; Zeng X; Payne L; Medina JR; Doepner-Buser C; Mangatt B
SLAS Discov; 2021 Feb; 26(2):216-229. PubMed ID: 33482073
[TBL] [Abstract][Full Text] [Related]
7. Rapid identification and validation of novel targeted approaches for Glioblastoma: A combined ex vivo-in vivo pharmaco-omic model.
Daher A; de Groot J
Exp Neurol; 2018 Jan; 299(Pt B):281-288. PubMed ID: 28923369
[TBL] [Abstract][Full Text] [Related]
8. Identification of the targeted therapeutic potential of doxycycline for a subset of gastric cancer patients.
Pandian J; Panneerpandian P; Devanandan HJ; Sekar BT; Balakrishnan K; Selvarasu K; Muthupandi K; Ganesan K
Ann N Y Acad Sci; 2020 May; 1467(1):94-111. PubMed ID: 31944316
[TBL] [Abstract][Full Text] [Related]
9. A high-throughput image-based screen for the identification of Bax/Bak-independent caspase activators against drug-resistant cancer cells.
Seervi M; Sobhan PK; Mathew KA; Joseph J; Pillai PR; Santhoshkumar TR
Apoptosis; 2014 Jan; 19(1):269-84. PubMed ID: 24220853
[TBL] [Abstract][Full Text] [Related]
10. High-Throughput Cell-Based Screening of Small Molecule KRAS Signaling Inhibitors Using a Homogeneous Time-Resolved Fluorescence (HTRF) Assay.
Smith BP; Rigby M; Ma R; Maciag AE
Methods Mol Biol; 2024; 2797():271-285. PubMed ID: 38570467
[TBL] [Abstract][Full Text] [Related]
11. A cell-based high-throughput assay for the screening of small-molecule inhibitors of p53-MDM2 interaction.
Li J; Zhang S; Gao L; Chen Y; Xie X
J Biomol Screen; 2011 Apr; 16(4):450-6. PubMed ID: 21471462
[TBL] [Abstract][Full Text] [Related]
12. Using β-Lactamase and NanoLuc Luciferase Reporter Gene Assays to Identify Inhibitors of the HIF-1 Signaling Pathway.
Khuc T; Hsu CW; Sakamuru S; Xia M
Methods Mol Biol; 2016; 1473():23-31. PubMed ID: 27518620
[TBL] [Abstract][Full Text] [Related]
13. Double-edged swords as cancer therapeutics: novel, orally active, small molecules simultaneously inhibit p53-MDM2 interaction and the NF-κB pathway.
Zhuang C; Miao Z; Wu Y; Guo Z; Li J; Yao J; Xing C; Sheng C; Zhang W
J Med Chem; 2014 Feb; 57(3):567-77. PubMed ID: 24428757
[TBL] [Abstract][Full Text] [Related]
14. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
15. Precision multidimensional assay for high-throughput microRNA drug discovery.
Haefliger B; Prochazka L; Angelici B; Benenson Y
Nat Commun; 2016 Feb; 7():10709. PubMed ID: 26880188
[TBL] [Abstract][Full Text] [Related]
16. Synergistic roles of p53 and HIF1α in human renal cell carcinoma-cell apoptosis responding to the inhibition of mTOR and MDM2 signaling pathways.
Liu QJ; Shen HL; Lin J; Xu XH; Ji ZG; Han X; Shang DH; Yang PQ
Drug Des Devel Ther; 2016; 10():745-55. PubMed ID: 26937175
[TBL] [Abstract][Full Text] [Related]
17. Development of a High-Throughput Gene Expression Screen for Modulators of RAS-MAPK Signaling in a Mutant RAS Cellular Context.
Severyn B; Nguyen T; Altman MD; Li L; Nagashima K; Naumov GN; Sathyanarayanan S; Cook E; Morris E; Ferrer M; Arthur B; Benita Y; Watters J; Loboda A; Hermes J; Gilliland DG; Cleary MA; Carroll PM; Strack P; Tudor M; Andersen JN
J Biomol Screen; 2016 Oct; 21(9):989-97. PubMed ID: 27461835
[TBL] [Abstract][Full Text] [Related]
18. Large-Scale Gene Expression Profiling Platform for Identification of Context-Dependent Drug Responses in Multicellular Tumor Spheroids.
Senkowski W; Jarvius M; Rubin J; Lengqvist J; Gustafsson MG; Nygren P; Kultima K; Larsson R; Fryknäs M
Cell Chem Biol; 2016 Nov; 23(11):1428-1438. PubMed ID: 27984028
[TBL] [Abstract][Full Text] [Related]
19. RKIP-mediated chemo-immunosensitization of resistant cancer cells via disruption of the NF-κB/Snail/YY1/RKIP resistance-driver loop.
Bonavida B
Crit Rev Oncog; 2014; 19(6):431-45. PubMed ID: 25597353
[TBL] [Abstract][Full Text] [Related]
20. An HTS-compatible 3D colony formation assay to identify tumor-specific chemotherapeutics.
Horman SR; To J; Orth AP
J Biomol Screen; 2013 Dec; 18(10):1298-308. PubMed ID: 23918920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
